We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+45.54%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$132M
AUM Growth
-$48M
Cap. Flow
-$51.8M
Cap. Flow %
-39.17%
Top 10 Hldgs %
58.69%
Holding
110
New
19
Increased
5
Reduced
6
Closed
42

Top Buys

Rank Stock Value
1
XENE icon
Xenon Pharmaceuticals
XENE
+$9.06M
2
GRI
GRI Bio
GRI
+$8.89M
3
IMGN
Immunogen Inc
IMGN
+$5.73M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$4.5M
5
JSPR icon
Jasper Therapeutics
JSPR
+$4.26M

Top Sells

Rank Stock Value
1
BLU
BELLUS Health Inc.
BLU
+$8.15M
2
ACLX
Arcellx
ACLX
+$4.62M
3
AVDL
Avadel Pharmaceuticals
AVDL
+$4.58M
4
GKOS icon
Glaukos
GKOS
+$4.56M
5
PEN icon
Penumbra
PEN
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 92.25%
2 Financials 1.18%
3 Technology 1.18%
4 Communication Services 0.44%
5 Materials 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSQH.WS icon
51
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.34M
$12.8K 0.01%
16,666
– –
OSAAW
52
DELISTED
ProSomnus, Inc. Warrant
OSAAW
$12.1K 0.01%
150,000
– –
NXLIW
53
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$11.6K 0.01%
105,000
– –
VSEEW
54
VSee Health Warrant
VSEEW
$241K
$9.99K 0.01%
150,000
– –
PEPLW
55
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$8.42K 0.01%
367,500
– –
MOBXW icon
56
Mobix Labs Warrants
MOBXW
$752K
$6.45K ﹤0.01%
150,000
– –
CYCUW
57
Cycurion Inc Warrant
CYCUW
$299K
$6.09K ﹤0.01%
100,000
– –
HCDIZ
58
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$5.72K ﹤0.01%
650,000
– –
CDTTW
59
CDT Equity Inc Warrant
CDTTW
$1.63M
$4.58K ﹤0.01%
100,000
– –
SRZNW icon
60
Surrozen Inc Warrant
SRZNW
$22.4K
$4.54K ﹤0.01%
82,233
– –
TGVCW
61
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$4.5K ﹤0.01%
200,000
– –
SLNAW
62
DELISTED
Selina Hospitality PLC Warrant
SLNAW
$4.33K ﹤0.01%
101,439
– –
OHAAW
63
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$4.25K ﹤0.01%
50,000
– –
MITAW
64
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$4.25K ﹤0.01%
28,333
– –
HCDIW
65
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$4.2K ﹤0.01%
600,000
– –
ZEV.WS
66
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$991 ﹤0.01%
32,608
-619,565
-95% -$14.9K
TCBPW
67
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$809 ﹤0.01%
18,823
– –
ACLX
68
DELISTED
Arcellx
ACLX
– –
-150,000
Closed -$4.62M
AKYA
69
DELISTED
Akoya BioSciences
AKYA
– –
-500,000
Closed -$4.09M
ATEC icon
70
Alphatec Holdings
ATEC
$1.41B
– –
-270,000
Closed -$4.21M
AVDL
71
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-500,000
Closed -$4.58M
BBIO icon
72
BridgeBio Pharma
BBIO
$16.2B
– –
-155,000
Closed -$2.33M
BHVN icon
73
Biohaven
BHVN
$2.16B
– –
-260,000
Closed -$3.55M
BLRX
74
BioLineRX
BLRX
$12.1M
– –
-56,991
Closed -$2.02M
BTM
75
DELISTED
Bitcoin Depot
BTM
– –
-7,143
Closed -$518K
1 2
3
4 5

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
LSA
Liberty Street Advisors New York $41.4M AUM 34.47% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return

Altium Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Altium Capital Management held 110 positions worth $132M, down 27% from $180M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Altium Capital Management withdrew a net $51.8M in Q2 2023, closing 42 positions and reducing 6 holdings. Its most notable exit was BELLUS Health Inc., an estimated $8.15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 85% a quarter earlier, followed by Financials and Technology.

Against the trend, Altium Capital Management opened a new position in Xenon Pharmaceuticals worth $8.78M.

  • Altium Capital Management's largest Q2 2023 buy was Xenon Pharmaceuticals: 228,000 shares worth $8.78M.
  • Altium Capital Management added most to Harmony Biosciences in Q2 2023, an estimated $4.14M increase.
  • Altium Capital Management's biggest Q2 2023 reduction was ADMA Biologics, cutting an estimated $1.82M.
  • Altium Capital Management fully exited BELLUS Health Inc. in Q2 2023, selling an estimated $8.15M.
  • Altium Capital Management's ten largest holdings make up 59% of its $132M portfolio in Q2 2023.
  • Altium Capital Management opened 19 new positions and closed 42 in Q2 2023.
  • Altium Capital Management's portfolio value fell 27% quarter-over-quarter to $132M.

Based on Altium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.